08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1127 23 1200 86 1047 173 1053
ERLYTX 77 4 209 10 122 13 79
GI 167 3 157 21 256 34 207
GU 413 8 417 57 694 100 609
LEUK 170 5 261 22 268 38 231
LUNG 209 4 209 19 231 32 195
LYMPH 427 8 417 31 377 67 408
MELAN 10 2 104 2 24 3 18
MMYEL 112 3 157 8 97 24 146
MULT 46 2 104 4 49 6 37
OTHER 43 0 0 1 12 2 12
Total 2801 62 3235 261 3177 492 2995

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 218 8 417 21 256 42 256
ERLYTX 2 1 52 1 12 1 6
GI 1 0 0 0 0 0 0
GU 6 0 0 1 12 3 18
LEUK 611 13 678 52 633 109 664
LUNG 365 9 470 28 341 73 444
LYMPH 1 0 0 0 0 1 6
OTHER 19 2 104 4 49 6 37
PEOLC 50 0 0 1 12 4 24
PREV 219 2 104 11 134 31 189
SXQOL 645 14 730 50 609 103 627
Total 2137 49 2555 169 2058 373 2271

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1127 23 1200 86 1047 173 1053
CCD 218 8 417 21 256 42 256
ERLYTX 79 5 261 11 134 14 85
GI 168 3 157 21 256 34 207
GU 419 8 417 58 706 103 627
LEUK 781 18 939 74 901 147 895
LUNG 574 13 678 47 572 105 639
LYMPH 428 8 417 31 377 68 414
MELAN 10 2 104 2 24 3 18
MMYEL 112 3 157 8 97 24 146
MULT 46 2 104 4 49 6 37
OTHER 62 2 104 5 61 8 49
PEOLC 50 0 0 1 12 4 24
PREV 219 2 104 11 134 31 189
SXQOL 645 14 730 50 609 103 627
Total 4938 111 5789 430 5235 865 5266

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 690 14 730 61 743 111 676
ERLYTX 59 4 209 10 122 13 79
GI 131 2 104 18 219 27 164
GU 304 4 209 42 511 70 426
LEUK 105 4 209 13 158 20 122
LUNG 135 3 157 14 170 22 134
LYMPH 280 3 157 16 195 39 237
MELAN 9 1 52 1 12 2 12
MMYEL 62 0 0 2 24 12 73
MULT 19 1 52 2 24 4 24
OTHER 43 0 0 1 12 2 12
Total 1837 36 1879 180 2190 322 1959

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 161 8 417 17 207 32 195
ERLYTX 2 1 52 1 12 1 6
GI 1 0 0 0 0 0 0
GU 6 0 0 1 12 3 18
LEUK 249 6 313 21 256 44 268
LUNG 227 8 417 23 280 54 329
LYMPH 1 0 0 0 0 1 6
OTHER 18 1 52 3 37 5 30
PEOLC 42 0 0 1 12 4 24
PREV 219 2 104 11 134 31 189
SXQOL 475 9 470 38 463 74 450
Total 1401 35 1825 116 1413 249 1515

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 889 22 1148 80 974 154 937
CCD 167 7 365 16 195 27 164
ERLYTX 61 5 261 11 134 14 85
GI 142 3 157 17 207 28 170
GU 338 4 209 40 487 71 432
LEUK 357 10 522 34 414 64 390
LUNG 397 13 678 42 511 82 499
LYMPH 281 3 157 16 195 40 244
MELAN 9 1 52 1 12 2 12
MMYEL 62 0 0 2 24 12 73
MULT 39 0 0 0 0 4 24
OTHER 108 1 52 4 49 7 43
PEOLC 45 1 52 4 49 7 43
PREV 219 2 104 11 134 31 189
SXQOL 475 9 470 38 463 74 450
Total 3589 81 4227 316 3848 617 3755

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 982 20 1044 77 937 160 974
ERLYTX 72 3 157 8 97 11 67
GI 98 2 104 12 146 22 134
GU 302 6 313 44 536 78 475
LEUK 139 4 209 18 219 33 201
LUNG 183 4 209 16 195 28 170
LYMPH 357 8 417 31 377 65 396
MMYEL 100 3 157 8 97 23 140
MULT 46 2 104 4 49 6 37
Total 2279 52 2714 218 2653 426 2594

08-NOV-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1891 44 2296 175 2131 336 2045
AFFIL 118 0 0 5 61 8 49
CCOP/NCORP 1229 27 1409 116 1412 227 1382
Non-SWOG 1695 35 1826 129 1571 289 1759
Total 4933 106 5531 425 5175 860 5235

08-NOV-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LUNG S1900J MET Amplification: Amivantamab Hyaluronidase 1 N 15-OCT-26

08-NOV-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 17
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 13
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 12
LUNG LUNGMAP NSCLC, Adv, Master 1 9
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 9
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 8
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LUNG LUNGMAP NSCLC, Adv, Master 2 4
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 4
CCD S2424CD A-PACT vs SOC for GOC communication 1 4
BREAST A012103 Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab 1 3
BREAST NRGBR009 Breast, EarlyStg, Adjuvant Chemo 1 3
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 2 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3